Securities Regulation and Corporate Governance

:

Securities Regulation and Corporate Governance > Posts > Coronavirus Disease 2019 Update: Impact under Nasdaq Rules of SEC Relief to Affected Companies
Coronavirus Disease 2019 Update: Impact under Nasdaq Rules of SEC Relief to Affected Companies

On March 8, 2020, we discussed on a post (available here) about the announcement (available hereby the Securities and Exchange Commission (the “Commission”) that providedconditional regulatory relief (Order available herefor certain filing obligations under the federal securities laws to companies impacted by the coronavirus disease 2019 (“COVID-19”).

In response to the Commission’s announcement, Nasdaq issued an Issuer Alert 2020-1 (available here)stating that Nasdaq-listed companies impacted by the COVID-19 outbreak that satisfy the conditions in the Commission’s Order and are eligible for the 45 day extension to file will not be deficient under Nasdaq Rule 5250(c) (which requires companies to timely file all required periodic financial reports with the Commissionavailable here), for failing to file Exchange Act reports by the existing deadlines and will not receive a deficiency letter from Nasdaq.

In addition, Nasdaq stated that Nasdaq-listed companies that satisfy the conditions and requirements in the Commission’s Order are exempt from Regulation 14A (including Rule 14a-16) and therefore will satisfy Nasdaq Listing Rules 5250(d) (available hereand 5620(b) (available here)Nasdaq’s response is in connection with the following requirements imposed on Nasdaq-listed companies:

• Rule 5250(d)(1) (available here), to make their annual reports available to shareholders;
• Rules 5250(d)(2) and (3) (available here), to make their quarterly and interim reports available to shareholders; and
• Rule 5620(b) (available here), to solicit proxies and provide proxy statements for meetings of shareholders.

Nasdaq recognizes that the COVID-19 outbreak also may create challenges and difficulties for some companies in satisfying other Nasdaq Listing Rules. Companies so impacted, or that have any questions regarding the application of the Commission’s Order to the Nasdaq Listing Rules, may contact their Listing Analyst or the Nasdaq Listing Qualifications Department at +1-301-978-8008 or continuedlisting@nasdaq.com

We would like to thank Rodrigo Surcan in our New York office for his work on this article.​


 ‭(Hidden)‬ Blog Tools


© Copyright 2018 Gibson, Dunn & Crutcher LLP.
Attorney Advertising. Prior results do not guarantee a similar outcome. All information provided on this site is for informational purposes only, does not constitute legal advice, is not confidential, and does not create an attorney-client relationship. Statements and content posted to this site do not represent the opinion of Gibson Dunn & Crutcher LLP ("Gibson Dunn"). Gibson Dunn makes no representations as to the accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors or omissions therein, nor for any losses, injuries, or damages arising from its display or use.